4//SEC Filing
M33 Growth I L.P. 4
Accession 0001213900-25-052626
CIK 0001799191other
Filed
Jun 8, 8:00 PM ET
Accepted
Jun 9, 4:15 PM ET
Size
10.4 KB
Accession
0001213900-25-052626
Insider Transaction Report
Form 4
M33 Growth I L.P.
Director10% Owner
Transactions
- Sale
Common Stock
2025-06-05$3.05/sh−673,676$2,054,712→ 13,950,557 total - Sale
Common Stock
2025-06-05$3.05/sh−76,324$232,788→ 1,272,724 total(indirect: See Footnote)
M33 Growth I GP LLC
Director10% Owner
Transactions
- Sale
Common Stock
2025-06-05$3.05/sh−76,324$232,788→ 1,272,724 total(indirect: See Footnote) - Sale
Common Stock
2025-06-05$3.05/sh−673,676$2,054,712→ 13,950,557 total
TOI M, LLC
Director10% Owner
Transactions
- Sale
Common Stock
2025-06-05$3.05/sh−673,676$2,054,712→ 13,950,557 total - Sale
Common Stock
2025-06-05$3.05/sh−76,324$232,788→ 1,272,724 total(indirect: See Footnote)
Footnotes (2)
- [F1]M33 Growth I GP LLC ("M33 LLC") is the general partner of M33 Growth I L.P. ("M33 LP") and may be deemed to beneficially own the shares held by M33 LP but disclaims beneficial ownership of these shares except to the extent of its pecuniary interest therein.
- [F2]These securities are held by TOI M, LLC.
Documents
Issuer
Oncology Institute, Inc.
CIK 0001799191
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001718621
Filing Metadata
- Form type
- 4
- Filed
- Jun 8, 8:00 PM ET
- Accepted
- Jun 9, 4:15 PM ET
- Size
- 10.4 KB